This is the talk I gave this week at the 2017 Interventional Orthopedics Foundation (IOF) Conference in Denver. Regrettably, the slides that made it into the computer were an old slide set with a few blanks. There’s nothing like being on the podium and seeing that the slides they have loaded are the wrong ones! For those of you who were there, this is the full talk in sequence. My focus was how we can use the chemical signatures in knee synovial fluid to predict who is going to respond well to a same-day stem cell treatment used to treat knee arthritis. Also, how we can use neural networks and artificial intelligence to help us make decisions about which regen med options will be best for patients. Enjoy!
*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.
About the Author
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…